Pomelo Care Secures $46 Million in Series B Funding to Revolutionize Maternal and Newborn Healthcare

Pomelo Care is thrilled to announce that we have successfully raised $46 million in our latest funding round, a remarkable milestone that underscores our commitment to transforming maternal and newborn health. At Pomelo Care, we believe that every pregnant individual and newborn deserves high-quality, accessible, and personalized care. We are dedicated to combining evidence-based practices with advanced technology to enhance healthcare outcomes for families during one of the most pivotal moments in their lives. This recent funding will enable us to expand our personalized care offerings and further develop innovative tools that empower families with the information and support they need throughout the pregnancy journey and beyond. With this capital infusion, we will be able to strengthen our technology platform, recruit additional expert professionals, and increase our outreach to underserved communities, ensuring that every family, regardless of their background, has access to the best possible care. We are excited about the opportunity to create meaningful change in the healthcare landscape and make a lasting impact on countless lives. As we move forward, our mission remains clear: to leverage cutting-edge technology and compassionate care to improve healthcare experiences and outcomes for expecting parents and their babies. We are grateful to our investors for their trust in our vision, and we look forward to embarking on this transformative journey together, ensuring that every family can thrive with the support they deserve.